Prosperity Financial Group, Inc. Dexcom Inc Transaction History

Prosperity Financial Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$110.31 - $140.45 $38,387 - $48,876	348 Added 13.57%	2,912 $330 Million
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $2,627 - $3,222	23 Added 0.91%	2,564 $356 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $4,755 - $7,822	63 Added 2.54%	2,541 $315 Million
Q3 2023 Nov 07, 2023	BUY	$86.06 - $137.93 $12,306 - $19,723	143 Added 6.12%	2,478 $231 Million
Q2 2023 Sep 12, 2023	BUY	$112.47 - $130.98 $16,308 - $18,992	145 Added 6.62%	2,335 $300 Million
Q1 2023 Sep 12, 2023	BUY	$104.0 - $122.92 $3,432 - $4,056	33 Added 1.53%	2,190 $254 Million
Q4 2022 Sep 12, 2023	BUY	$84.98 - $122.67 $183,301 - $264,599	2,157 New	2,157 $244 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Prosperity Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Prosperity Financial Group, Inc. with notifications on news.